The effect of receptor protein tyrosine phosphatase kappa on the change of cell adhesion and proliferation induced by N-acetylglucosaminyltransferase V

Journal of Cellular Biochemistry

Volumn 109, Issue 1, 2010, Pages 113-123

  Wang, Can ^a,b,c   Li, Zengxia ^a   Yang, Zhaohua ^a   Zhao, Hongbo ^a,b   Yang, Yong ^a   Chen, Kangli ^a   Cai, Xiumei ^a   Wang, Liying ^a,b   Shi, Yinghong ^a   Qiu, Shuangjian ^a   Fan, Jia ^a   Zha, Xiliang ^a,b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI INSTITUTE FOR FOOD AND DRUG CONTROL   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

catenin; Adhesion; N acetylglucosaminyltransferase V; Proliferation; Receptor protein tyrosine phosphatase kappa

Indexed keywords

ALPHA 1,3(6) MANNOSYLGLYCOPROTEIN BETA 1,6 N ACETYLGLUCOSAMINYLTRANSFERASE; BETA CATENIN; CYCLIN D1; FURIN; GLYCOSYLTRANSFERASE; PROTEIN TYROSINE KINASE; RECEPTOR PROTEIN TYROSINE PHOSPHATASE KAPPA; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CANCER CELL CULTURE; CELL ADHESION; CELL PROLIFERATION; GENE OVEREXPRESSION; GLYCOSYLATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BETA CATENIN; BLOTTING, WESTERN; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOPRECIPITATION; N-ACETYLGLUCOSAMINYLTRANSFERASES; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 73849109584     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22387     Document Type: Article

References (49)

1. Arango J, Pierce M. 1988. Comparison of N-acetylglucosaminyltransferase V activities in Rous sarcoma-transformed baby hamster kidney (RS-BHK) and BHK cells. J Cell Biochem 37:225-231.
2. Brady-Kalnay SM, Flint AJ, Tonks NK. 1993. Homophilic binding of PTP mu, a receptor-type protein tyrosine phosphatase, can mediate cell-cell aggregation. J Cell Biol 122:961-972.
3. Brockhausen I, Carver JP, Schachter H. 1988. Control of glycoprotein synthesis. The use of oligosaccharide substrates and HPLC to study the sequential pathway for N-acetylglucosaminyltransferases I, II, III, IV, V, and VI in the biosynthesis of highly branched N-glycans by hen oviduct membranes. Biochem Cell Biol 66:1134-1151.
4. Campan M, Yoshizumi M, Seidah NG, Lee ME, Bianchi C, Haber E. 1996. Increased proteolytic processing of protein tyrosine phosphatase mu in confluent vascular endothelial cells: The role of PC5, a member of the subtilisin family. Biochemistry 35:3797-3802.
5. Chen L, Zhang W, Fregien N, Pierce M. 1998. The her-2/neu oncogene stimulates the transcription of N-acetylglucosaminyltransferase V and expression of its cell surface oligosaccharide products. Oncogene 17: 2087-2093.
6. Cheng J, Wu K, Armanini M, O'Rourke N, Dowbenko D, Lasky LA. 1997. A novel protein-tyrosine phosphatase related to the homotypically adhering kappa and mu receptors. J Biol Chem 272:7264-7277.
7. Demetriou M, Nabi IR, Coppolino M, Dedhar S, Dennis JW. 1995. Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J Cell Biol 130:383-392.
8. Dennis JW, Laferte S. 1989. Oncodevelopmental expression of GlcNAc beta 1-6Man alpha 1-6Man beta 1-branched asparagine-linked oligosaccharides in murine tissues and human breast carcinomas. Cancer Res 49:945-950.
9. Eswaran J, Debreczeni JE, Longman E, Barr AJ, Knapp S. 2006. The crystal structure of human receptor protein tyrosine phosphatase kappa phosphatase domain 1. Protein Sci 15:1500-1505.
10. Fernandes B, Sagman U, Auger M, Demetrio M, Dennis JW. 1991. Beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res 51:718-723.
11. Fuchs M, Muller T, Lerch MM, Ullrich A. 1996. Association of human protein-tyrosine phosphatase kappa with members of the armadillo family. J Biol Chem 271:16712-16719.
12. Gebbink MF, Zondag GC, Wubbolts RW, Beijersbergen RL, van Etten I, Moolenaar WH. 1993. Cell-cell adhesion mediated by a receptor-like protein tyrosine phosphatase. J Biol Chem 268:16101-16104.
13. Granovsky M, Fata J, Pawling J, Muller WJ, Khokha R, Dennis JW. 2000. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med 6:306-312.
14. Gujral TS, van Veelen W, Richardson DS, Myers SM, Meens JA, Acton DS, Dunach M, Elliott BE, Hoppener JW, Mulligan LM. 2008. A novel RET kinase-beta-catenin signaling pathway contributes to tumorigenesis in thyroid carcinoma. Cancer Res 68:1338-1346.
15. Guo HB, Zhang QS, Chen HL. 2000. Effects of H-ras and v-sis overexpression on N-acetylglucosaminyltransferase V and metastasis-related phenotypes in human hepatocarcinoma cells. J Cancer Res Clin Oncol 126:263-270.
16. Guo HB, Lee I, Kamar M, Akiyama SK, Pierce M. 2002. Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration. Cancer Res 62:6837-6845.
17. Handerson T, Camp R, Harigopal M, Rimm D, Pawelek J. 2005. Beta1,6-branched oligosaccharides are increased in lymph node metastases and predict poor outcome in breast carcinoma. Clin Cancer Res 11:2969-2973.
18. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW. 1998. Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512.
19. Hirata T, Takagi S, Fujisawa H. 1993. The membrane protein A5, a putative neuronal recognition molecule, promotes neurite outgrowth. Neurosci Res 17:159-169.
20. Ihara S, Miyoshi E, Ko JH, Murata K, Nakahara S, Honke K, Dickson RB, Lin CY, Taniguchi N. 2002. Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching. J Biol Chem 277:16960-16967.
21. Jean C, Blanc A, Prade-Houdellier N, Ysebaert L, Hernandez-Pigeon H, Al Saati T, Haure MJ, Coluccia AM, Charveron M, Delabesse E, Laurent G. 2009. Epidermal growth factor receptor/beta-catenin/T-cell factor 4/matrix metalloproteinase 1: A new pathway for regulating keratinocyte invasiveness after UVA irradiation. Cancer Res 69:3291-3299.
22. Jiang W, Gorbea CM, Flannery AV, Beynon RJ, Grant GA, Bond JS. 1992. The alpha subunit of meprin A. Molecular cloning and sequencing, differential expression in inbred mouse strains, and evidence for divergent evolution of the alpha and beta subunits. J Biol Chem 267:9185-9193.
23. Kariya Y, Kato R, Itoh S, Fukuda T, Shibukawa Y, Sanzen N, Sekiguchi K, Wada Y, Kawasaki N, Gu J. 2008. N-Glycosylation of laminin-332 regulates its biological functions. A novel function of the bisecting GlcNAc. J Biol Chem 283:33036-33045.
24. Kim YS, Kang HY, Kim JY, Oh S, Kim CH, Ryu CJ, Miyoshi E, Taniguchi N, Ko JH. 2006. Identification of target proteins of N-acetylglucosaminyl transferase V in human colon cancer and implications of protein tyrosine phosphatase kappa in enhanced cancer cell migration. Proteomics 6:1187-1191.
25. Kim YS, Hwang SY, Kang HY, Sohn H, Oh S, Kim JY, Yoo JS, Kim YH, Kim CH, Jeon JH, Lee JM, Kang HA, Miyoshi E, Taniguchi N, Yoo HS, Ko JH. 2008. Functional proteomics study reveals that N-acetylglucosaminyltransferase V reinforces the invasive/metastatic potential of colon cancer through aberrant glycosylation on tissue inhibitor of metalloproteinase-1. Mol Cell Proteomics 7:1-14.
26. Ko JH, Miyoshi E, Noda K, Ekuni A, Kang R, Ikeda Y, Taniguchi N. 1999. Regulation of the GnT-V promoter by transcription factor Ets-1 in various cancer cell lines. J Biol Chem 274:22941-22948.
27. Korczak B, Le T, Elowe S, Datti A, Dennis JW. 2000. Minimal catalytic domain of N-acetylglucosaminyltransferase V. Glycobiology 10:595-599.
28. Li J, Wang XM, Wang Q, Yang M, Feng XC, Shen ZH. 2007. Down-regulation of N-acetylglucosaminyltransferase-V induces ER stress by changing glycosylation and function of GLUT1. Arch Biochem Biophys 463:102-109.
29. Mazieres J, He B, You L, Xu Z, Jablons DM. 2005. Wnt signaling in lung cancer. Cancer Lett 222:1-10.
30. Moon RT, Bowerman B, Boutros M, Perrimon N. 2002. The promise and perils of Wnt signaling through beta-catenin. Science 296:1644-1646.
31. Novellino L, De Filippo A, Deho P, Perrone F, Pilotti S, Parmiani G, Castelli C. 2008. PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic beta-catenin and affects membrane distribution of beta-catenin/ E-cadherin complexes in cancer cells. Cell Signal 20:872-883.
32. Peifer M. 1997. Beta-catenin as oncogene: The smoking gun. Science 275: 1752-1753.
33. Osaw T, Tsuji T. 1987. Fractionation and structural assessment of oligosaccharides and glycopeptides by use of immobilized lectins. Annu Rev Biochem 56:21-42.
34. Pierce M, Buckhaults P, Chen L, Fregien N. 1997. Regulation of N-acetylglucosaminyltransferase V and Asn-linked oligosaccharide beta(1,6) branching by a growth factor signaling pathway and effects on cell adhesion and metastatic potential. Glycoconj J 14:623-630.
35. Sap J, Jiang YP, Friedlander D, Grumet M, Schlessinger J. 1994. Receptor tyrosine phosphatase R-PTP-kappa mediates homophilic binding. Mol Cell Biol 14:1-9.
36. Schreiber E, Matthias P, Muller MM, Schaffner W. 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res 17:6419.
37. Seelentag WK, Li WP, Schmitz SF, Metzger U, Aeberhard P, Heitz PU, Roth J. 1998. Prognostic value of beta1,6-branched oligosaccharides in human colorectal carcinoma. Cancer Res 58:5559-5564.
38. Takagi S, Hirata T, Agata K, Mochii M, Eguchi G, Fujisawa H. 1991. The A5 antigen, a candidate for the neuronal recognition molecule, has homologies to complement components and coagulation factors. Neuron 7:295-307.
39. Takano Y, Morimura Y, Yamada H, Yanagida K, Sato A, Suzuki O, Suzuki T. 2000. Myxoid leiomyosarcoma of the uterus. Fukushima J Med Sci 46:41-47.
40. Tetsu O, McCormick F. 1999. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426.
41. Vleminckx KL, Deman JJ, Bruyneel EA, Vandenbossche GM, Keirsebilck AA, Mareel MM, van Roy FM. 1994. Enlarged cell-associated proteoglycans abolish E-cadherin functionality in invasive tumor cells. Cancer Res 54:873-877.
42. Wang L, Liang Y, Li Z, Cai X, Zhang W, Wu G, Jin J, Fang Z, Yang Y, Zha X. 2007. Increase in beta1-6 GlcNAc branching caused by Nacetylglucosaminyltransferase V directs integrin beta1 stability in human hepatocellular carcinoma cell line SMMC-7721. J Cell Biochem 100:230-241.
43. Wang C, Yang Y, Yang Z, Liu M, Li Z, Sun L, Mei C, Chen H, Chen L, Wang L, Zha X. 2009. EGF-mediated migration signaling activated by N-acetylglucosaminyltransferase-V via receptor protein tyrosine phosphatase kappa. Arch Biochem Biophys 486:64-72.
44. Yamamoto H, Swoger J, Greene S, Saito T, Hurh J, Sweeley C, Leestma J, Mkrdichian E, Cerullo L, Nishikawa A, Ihara Y, Taniguchi N, Moskal JR. 2000. Beta1,6-N-acetylglucosamine-bearing N-glycans in human gliomas: Implications for a role in regulating invasivity. Cancer Res 60:134-142.
45. Yang Y, Gil MC, Choi EY, Park SH, Pyun KH, Ha H. 1997. Molecular cloning and chromosomal localization of a human gene homologous to the murine R-PTP-kappa, a receptor-type protein tyrosine phosphatase. Gene 186:77-82.
46. Yang X, Li J, Geng M. 2008. N-acetylglucosaminyltransferase V modifies TrKA protein, regulates the receptor function. Cell Mol Neurobiol 28:663-670.
47. Yao M, Zhou DP, Jiang SM, Wang QH, Zhou XD, Tang ZY, Gu JX. 1998. Elevated activity of N-acetylglucosaminyltransferase V in human hepatocellular carcinoma. J Cancer Res Clin Oncol 124:27-30.
48. Zhang W, Yang J, Liu Y, Chen X, Yu T, Jia J, Liu C. 2009. PR55alpha, a regulatory subunit of PP2A, specifically regulates PP2A-mediated beta-catenin dephosphorylation. J Biol Chem 284: 22649-22656.
49. Zondag GC, Koningstein GM, Jiang YP, Sap J, Moolenaar WH, Gebbink MF. 1995. Homophilic interactions mediated by receptor tyrosine phosphatases mu and kappa. A critical role for the novel extracellular MAM domain. J Biol Chem 270:14247-14250.